TL;DR: The Centers for Medicare & Medicaid Services modified NCD 212, its coverage policy for noninvasive tests of carotid function, effective March 7, 2026. Here's what billing teams need to know.
CMS noninvasive carotid testing coverage policy (NCD 212 Medicare) governs how Medicare pays for a broad set of direct and indirect carotid studies — from Doppler flow velocity to oculoplethysmography. This update to NCD 212 does not add or remove covered tests, but it reaffirms the framework billing teams must apply when documenting medical necessity and submitting claims for carotid function studies. The policy does not list specific CPT codes, which means your MAC's local coverage determinations carry most of the billing weight here. That gap is the issue.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Noninvasive Tests of Carotid Function |
| Policy Code | NCD 212 |
| Change Type | Modified |
| Effective Date | 2026-03-07 |
| Impact Level | Medium |
| Specialties Affected | Vascular surgery, neurology, radiology, cardiology, internal medicine |
| Key Action | Confirm your MAC's LCD maps to each carotid test type your practice bills — NCD 212 defers code-level guidance to local contractors |
CMS Noninvasive Carotid Testing Coverage Criteria and Medical Necessity Requirements 2026
NCD 212 covers noninvasive tests of carotid function when physicians use them to study and diagnose carotid disease. That's the standard — study and diagnose. If documentation doesn't connect the test to a clinical question about carotid disease, you're exposed to claim denial.
The policy splits covered tests into two categories: direct and indirect. Direct tests examine the anatomy and physiology of the carotid artery itself. Indirect tests examine hemodynamic changes in the distal beds — specifically the orbital and cerebral circulations.
Medical necessity for these studies depends on which type of test you're ordering and why. A Doppler flow velocity study (a direct test) and oculoplethysmography (an indirect test) serve different diagnostic purposes. Your documentation needs to reflect that distinction. Generic language like "carotid evaluation" won't hold up under review.
Direct tests covered under NCD 212 include:
| # | Covered Indication |
|---|---|
| 1 | Carotid phonoangiography |
| 2 | Direct bruit analysis |
| 3 | Spectral bruit analysis |
| 4 | Doppler flow velocity |
| 5 | Ultrasound imaging, including real-time |
| 6 | B-scan and Doppler devices |
Indirect tests covered under NCD 212 include:
| # | Covered Indication |
|---|---|
| 1 | Periorbital directional Doppler ultrasonography |
| 2 | Oculoplethysmography |
| 3 | Ophthalmodynamometry |
CMS acknowledges that test names are not standardized across the industry. That's not a minor footnote — it directly affects how claims get coded. Your coding team may encounter the same test described differently by two different ordering physicians. The policy explicitly states that local medical consultants should make coverage determinations when test names don't match the NCD list. That defers authority to your Medicare Administrative Contractor, not CMS directly.
Prior authorization is not required under NCD 212 for these studies. But the absence of prior authorization requirements doesn't mean claims go through unchallenged. Medical necessity documentation still needs to be airtight. Reviewers will look at whether the test type matches the clinical indication.
Reimbursement for these tests runs through your MAC's fee schedule. NCD 212 establishes that these tests are covered diagnostic services under Medicare — the benefit category is "Diagnostic Tests (other)" — but the actual payment rates are set locally. Call your MAC if you're unclear on applicable rates for the specific test types your practice performs.
Coverage Indications at a Glance
| Indication / Test Type | Status | Relevant Codes | Notes |
|---|---|---|---|
| Carotid phonoangiography (direct test) | Covered | Not specified in NCD 212 — check MAC LCD | Document clinical basis for carotid disease workup |
| Direct bruit analysis (direct test) | Covered | Not specified in NCD 212 — check MAC LCD | Test name non-standardization is a known issue; confirm MAC-accepted terminology |
| Spectral bruit analysis (direct test) | Covered | Not specified in NCD 212 — check MAC LCD | Same documentation standard applies |
| Doppler flow velocity (direct test) | Covered | Not specified in NCD 212 — check MAC LCD | One of the most commonly billed carotid studies; confirm CPT with your MAC |
| Ultrasound imaging, including real-time B-scan and Doppler (direct test) | Covered | Not specified in NCD 212 — check MAC LCD | Ultrasound-based direct tests are the highest-volume category here |
| Periorbital directional Doppler ultrasonography (indirect test) | Covered | Not specified in NCD 212 — check MAC LCD | Indirect test — examine hemodynamic changes in orbital circulation |
| Oculoplethysmography (indirect test) | Covered | Not specified in NCD 212 — check MAC LCD | Less common; confirm your MAC still accepts this as a billable service |
| Ophthalmodynamometry (indirect test) | Covered | Not specified in NCD 212 — check MAC LCD | Confirm whether your MAC LCD has specific criteria for this indirect test |
| Tests not on the NCD list but related to carotid function | Covered if MAC approves | Varies | NCD 212 explicitly states the list is not exhaustive — MAC local medical consultants make the call |
CMS Noninvasive Carotid Testing Billing Guidelines and Action Items 2026
The absence of specific CPT codes in NCD 212 is the real operational challenge this policy creates. Your billing team can't rely on NCD 212 alone to confirm coverage. Here's what to do before and after the effective date of March 7, 2026.
| # | Action Item |
|---|---|
| 1 | Pull your MAC's LCD for noninvasive carotid studies now. NCD 212 explicitly defers code-level guidance to local medical consultants. Your MAC's local coverage determination is where you'll find the CPT codes, ICD-10 diagnosis codes, and documentation requirements that actually govern claim submission. If you're billing in a multi-MAC geography, pull every relevant LCD. |
| 2 | Audit your charge capture for each test type against the direct/indirect classification. NCD 212 organizes coverage around this two-category framework. If your charge capture doesn't reflect this distinction — if every carotid study goes through the same workflow regardless of type — you're creating unnecessary denial risk. Separate your direct and indirect test workflows before March 7, 2026. |
| 3 | Address the test name standardization problem head-on. CMS explicitly warns that test names are not standardized. Build a crosswalk between the clinical terminology your ordering physicians use and the NCD 212 test descriptions. When names don't match, your MAC's local medical consultant makes the coverage call — which means your documentation needs to be descriptive enough to map back to a covered test type. |
| 4 | Review your medical necessity templates for carotid studies. Generic documentation won't survive a post-payment audit. Templates need to capture the specific clinical question being answered — is this a direct anatomical study of the carotid artery, or an indirect hemodynamic assessment of the orbital or cerebral circulation? Noninvasive carotid testing billing requires that distinction in the record. |
| 5 | Verify that oculoplethysmography and ophthalmodynamometry are still active services at your MAC. These indirect tests are the least commonly performed of the covered categories. Some MACs may have narrow or outdated LCD guidance for them. Confirm before billing — a claim denial on a rarely-submitted code can create an overpayment exposure if you've been billing it without active MAC coverage. |
| 6 | Don't assume prior authorization is off the table for all payers. NCD 212 governs Medicare. If your patients also carry commercial coverage, those payers may have separate prior authorization requirements for carotid ultrasound and related studies. Carotid testing billing guidelines vary significantly across commercial plans. Check each payer's policy independently. |
| 7 | Flag this policy for your compliance officer if your practice bills high volumes of carotid studies. The combination of no specific CPT codes, non-standardized test nomenclature, and MAC-level deference means there's real ambiguity in how this coverage policy applies to specific services. If you're running high volume on these studies, get your compliance officer and billing consultant involved before the March 7, 2026 effective date to make sure your LCD mapping and documentation standards are aligned. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Noninvasive Carotid Testing Under NCD 212
A Note on Code Availability
NCD 212 does not list specific CPT, HCPCS, or ICD-10 codes. This is not a documentation gap in this article — it reflects the actual policy. CMS structured NCD 212 to define covered test categories descriptively, not by code. Code-level guidance lives at the MAC level in local coverage determinations.
This matters for your billing team in a practical way. When a payer policy doesn't specify codes, you don't have a national-level safety net for code selection. A CPT code that maps to a covered direct carotid test in one MAC jurisdiction may be handled differently in another. Your LCD is the governing document for code-level decisions.
Where to Find Applicable Codes
| Resource | What You'll Find |
|---|---|
| Your MAC's LCD for noninvasive carotid studies | CPT codes, ICD-10 diagnosis codes, documentation requirements |
| CMS Coverage Database (NCD 212 source) | High-level coverage framework — test categories, direct vs. indirect classification |
| AMA CPT Code Set | Current CPT codes for carotid duplex, Doppler, and related vascular studies |
| CMS Physician Fee Schedule | Reimbursement rates by locality for applicable CPT codes |
Search your MAC's LCD database using terms like "carotid," "Doppler," "cerebrovascular," or "vascular ultrasound." Cross-reference what you find against the direct and indirect test categories in NCD 212. If your MAC's LCD doesn't clearly address a test type your practice performs, contact your MAC directly before billing. A proactive inquiry is far cheaper than a denied claim or a post-payment audit finding.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.